NYSE : BME

BlackRock Health Sciences Trust

$42.56 USD

-$0.06 (-0.14%)

Volume
55.89K
Average Volume
48.4K
Market Capitalization
$550.05M
P/E Ratio
7.15
Dividend Yield
7.39%
Price Target
Year High
$44.35
Year Low
$35.03
Day High
—
Day Low
—
Payout Ratio
$0.53
Current Ratio
$0.00
Company Overview

NYSE

John Perlowski

Asset Management

Financial Services

BME

N/A

US

USD

https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund

212 810 5300

09250W107

0001314966

Liquidity Metrics

0.00

0.00

0.00

0.00

0.53

Sales & Valuation

$36.16M

20.59

0.97

22.13

1.92

Profitability

$5.92

$76.97M

288.16%

288.16%

14.30%

13.50%

P/E Metrics

7.15

-0.01

-0.01

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Poll Results

About BlackRock Health Sciences Trust (NYSE:BME) Stock

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States. ...

B&M shares slide but analysts say quarter changes little

2026-07-15 09:07:21

B&M European Value Retail SA (LSE:BME) shares fell after the discount retailer reported a decline in underlying UK sales, although analysts said the update was largely in line with expectations and did little to alter the investment case. Shares in the FTSE 250-listed group fell 5.8% to 192.1p by early afternoon on Wednesday.

B&M reports improved UK trading and strong sales in France

2026-07-15 02:58:36

B&M European Value Retail SA (LSE:BME) reported first-quarter sales growth of 2% as strong trading in France and steady growth at Heron Foods helped lift group revenue despite weaker trading in its core UK business. The discount retailer said revenue rose to £1.43 billion in the 13 weeks to 27 June from a year earlier.

Broker puts B&M under review and warns re-rating is unlikely despite shares surging 15.5%

2026-06-03 06:14:55

B&M European Value Retail SA (LSE:BME) shares surged 15.5% to 196.9p after full-year results came in line with guidance, but Shore Capital has placed the discount retailer under review and cautioned that the conditions for a meaningful re-rating are not yet in place. The broker, which had previously held a 'buy' rating on the stock, acknowledged that the financial year to March represented progress after what management itself described as a difficult year.

B&M profits slump as discounter pushes turnaround plan

2026-06-03 02:43:06

B&M European Value Retail SA (LSE:BME) reported a 38% fall in annual profits as weak trading in the UK was exacerbated by "execution issues", though it said its turnaround programme is beginning to show signs of progress. The FTSE 250-listed discount retailer posted adjusted profit before tax of £284 million for the 2026 financial year, down from £455 million a year earlier, whjile adjusted EBITDA fell 26% to £459 million.

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

2026-05-29 16:31:00

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Deutsche Bank downgrades B&M and Wickes as retailers brace for consumer pressure

2026-05-29 07:07:31

Deutsche Bank has downgraded B&M European Value Retail SA (LSE:BME) and Wickes Group PLC (LSE:WIX) from 'hold' to 'sell', cutting price targets sharply as inflationary headwinds threaten to test consumer spending and retailer margins more severely. B&M's target was cut from 175p to 155p, while Wickes Group saw its target slashed from 235p to 165p, reflecting analyst Adam Cochrane's concern about the timing and intensity of upcoming demand erosion.

The Closed-End Fund Portfolio That Quietly Pays a 71-Year-Old $61,000 a Year on $850,000 and Trades at a Persistent Discount

2026-05-23 08:12:10

A 71-year-old retiree holding $850,000 across a basket of closed-end funds is generating roughly $61,000 a year in distributions. That works out to a blended yield of about 7.2%, with several of the underlying funds trading at discounts of 8% to 12% below net asset value. The arithmetic itself is straightforward: income target divided by... The Closed-End Fund Portfolio That Quietly Pays a 71-Year-Old $61,000 a Year on $850,000 and Trades at a Persistent Discount

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

2026-05-22 10:27:44

BlackRock Health Sciences Trust remains a steady income generator, never having cut its regular distribution since inception, despite recent lackluster results. BME's discount has narrowed, resulting in some outperformance relative to XLV on total share price return. I continue to hold BME for long-term income, viewing the current healthcare sector undervaluation as a potential opportunity for cautious, incremental additions.

Frequently Asked Questions

What is the current BlackRock Health Sciences Trust (BME) stock price?

BlackRock Health Sciences Trust(NYSE:BME) stock price is $42.56 in the last trading session. During the trading session, BME stock reached the peak price of $44.35 while $35.03 was the lowest point it dropped to. The percentage change in BME stock occurred in the recent session was --0.14% while the dollar amount for the price change in BME stock was -$0.06.

BME's industry and sector of operation?

The NYSE listed BME is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of BME?

Kyle G. McClements | Portfolio Manager
Charles Choon Sik Park | Chief Compliance Officer and Anti-Money Laundering Officer
Xiang Liu | Portfolio Manager
Christopher Accettella | Portfolio Manager
Erin Xie | Portfolio Manager

How many employees does BME have?

Number of BME employees currently stands at None. BME operates from 100 Bellevue Parkway, Wilmington, NY 10001, US.

Link for BME official website?

Official Website of BME is: https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund

How do I contact BME?

BME could be contacted at phone #212 810 5300 and can also be accessed through its website. BME operates from 100 Bellevue Parkway, Wilmington, NY 10001, US.

How many shares of BME are traded daily?

The average number of BME shares traded daily for last 3 months was 48.4K.

What is the market cap of BME currently?

The market value of BME currently stands at $550.05M with its latest stock price at $42.56